1. Biochemistry and Chemical Biology
  2. Structural Biology and Molecular Biophysics

A histidine pH sensor regulates activation of the Ras-specific guanine nucleotide exchange factor RasGRP1

  1. Yvonne Vercoulen
  2. Yasushi Kondo
  3. Jeffrey S Iwig
  4. Alex Janssen
  5. Katharine A White
  6. Mojtaba Amini
  7. Diane L Barber
  8. John Kuriyan  Is a corresponding author
  9. Jeroen P Roose  Is a corresponding author
  1. University of California, San Francisco, United States
  2. University of California, Berkeley, United States
  3. University Medical Center Utrecht, Netherlands
https://doi.org/10.7554/eLife.29002
Share this article
Cite this article
  1. Yvonne Vercoulen
  2. Yasushi Kondo
  3. Jeffrey S Iwig
  4. Alex Janssen
  5. Katharine A White
  6. Mojtaba Amini
  7. Diane L Barber
  8. John Kuriyan
  9. Jeroen P Roose
(2017)
A histidine pH sensor regulates activation of the Ras-specific guanine nucleotide exchange factor RasGRP1
eLife 6:e29002.
https://doi.org/10.7554/eLife.29002
  2. Download BibTeX
  3. Download .RIS

Abstract

RasGRPs are guanine nucleotide exchange factors that are specific for Ras or Rap, and are important regulators of cellular signaling. Aberrant expression or mutation of RasGRPs results in disease. An analysis of RasGRP1 SNP variants led to the conclusion that the charge of His 212 in RasGRP1 alters signaling activity and plasma membrane recruitment, indicating that His 212 is a pH sensor that alters the balance between the inactive and active forms of RasGRP1. To understand the structural basis for this effect we compared the structure of autoinhibited RasGRP1, determined previously, to that of active RasGRP4:H-Ras and RasGRP2:Rap1b complexes. The transition from the autoinhibited to the active form of RasGRP1 involves the rearrangement of an inter-domain linker that displaces inhibitory inter-domain interactions. His 212 is located at the fulcrum of these conformational changes, and structural features in its vicinity are consistent with its function as a pH-dependent switch.

Data availability

The following data sets were generated
    1. Kondo
    2. Y.
    3. Iwig
    4. J.S.
    5. Kuriyan
    6. J.
    (2017) Structure of RasGRP2 in complex with Rap1B
    Publicly available at the RCSB Protein Data Bank (Accession no: 6AXF).
    http://www.pdb.org/pdb/search/structidSearch.do?structureId=6AXF
    1. Kondo
    2. Y.
    3. Iwig
    4. J.S.
    5. Kuriyan
    6. J.
    (2017) Structure of RasGRP4 in complex with HRas
    Publicly available at the RCSB Protein Data Bank (Accession no: 6AXG).
    http://www.pdb.org/pdb/search/structidSearch.do?structureId=6AXG

Article and author information

Author details

  1. Yvonne Vercoulen

    Department of Anatomy, University of California, San Francisco, San Francisco, United States
    Competing interests
    No competing interests declared.

  2. Yasushi Kondo

    Department of Molecular and Cell Biology, University of California, Berkeley, Berkeley, United States
    Competing interests
    No competing interests declared.

  3. Jeffrey S Iwig

    Department of Molecular and Cell Biology, University of California, Berkeley, Berkeley, United States
    Competing interests
    No competing interests declared.

  4. Alex Janssen

    Department of Anatomy, University of California, San Francisco, San Francisco, United States
    Competing interests
    No competing interests declared.

  5. Katharine A White

    Department of Cell and Tissue Biology, University of California, San Francisco, San Francisco, United States
    Competing interests
    No competing interests declared.

  6. Mojtaba Amini

    Molecular Cancer Research, Center for Molecular Medicine, University Medical Center Utrecht, Utrecht, Netherlands
    Competing interests
    No competing interests declared.

  7. Diane L Barber

    Department of Cell and Tissue Biology, University of California, San Francisco, San Francisco, United States
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-7185-9435

  8. John Kuriyan

    Department of Molecular and Cell Biology, University of California, Berkeley, Berkeley, United States
    For correspondence
    jkuriyan@mac.com
    Competing interests
    John Kuriyan, Senior editor, eLife.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-4414-5477

  9. Jeroen P Roose

    Department of Anatomy, University of California, San Francisco, San Francisco, United States
    For correspondence
    jeroen.roose@ucsf.edu
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-4746-2811

Funding

National Institute of Allergy and Infectious Diseases

  • Jeroen P Roose

National Cancer Institute

  • Katharine A White
  • Diane L Barber

Marie Curie Cancer Care

  • Yvonne Vercoulen

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Copyright

© 2017, Vercoulen et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 3,115
    views
  • 470
    downloads
  • 37
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Yvonne Vercoulen
  2. Yasushi Kondo
  3. Jeffrey S Iwig
  4. Alex Janssen
  5. Katharine A White
  6. Mojtaba Amini
  7. Diane L Barber
  8. John Kuriyan
  9. Jeroen P Roose
(2017)
A histidine pH sensor regulates activation of the Ras-specific guanine nucleotide exchange factor RasGRP1
eLife 6:e29002.
https://doi.org/10.7554/eLife.29002

Share this article

https://doi.org/10.7554/eLife.29002

Categories and tags

Further reading

    1. Biochemistry and Chemical Biology
    2. Microbiology and Infectious Disease

    The nanoscale organization of the Nipah virus fusion protein informs new membrane fusion mechanisms

    Qian Wang, Jinxin Liu ... Qian Liu
    Research Article

    Paramyxovirus membrane fusion requires an attachment protein for receptor binding and a fusion protein for membrane fusion triggering. Nipah virus (NiV) attachment protein (G) binds to ephrinB2 or -B3 receptors, and fusion protein (F) mediates membrane fusion. NiV-F is a class I fusion protein and is activated by endosomal cleavage. The crystal structure of a soluble GCN4-decorated NiV-F shows a hexamer-of-trimer assembly. Here, we used single-molecule localization microscopy to quantify the NiV-F distribution and organization on cell and virus-like particle membranes at a nanometer precision. We found that NiV-F on biological membranes forms distinctive clusters that are independent of endosomal cleavage or expression levels. The sequestration of NiV-F into dense clusters favors membrane fusion triggering. The nano-distribution and organization of NiV-F are susceptible to mutations at the hexamer-of-trimer interface, and the putative oligomerization motif on the transmembrane domain. We also show that NiV-F nanoclusters are maintained by NiV-F–AP-2 interactions and the clathrin coat assembly. We propose that the organization of NiV-F into nanoclusters facilitates membrane fusion triggering by a mixed population of NiV-F molecules with varied degrees of cleavage and opportunities for interacting with the NiV-G/receptor complex. These observations provide insights into the in situ organization and activation mechanisms of the NiV fusion machinery.

    1. Biochemistry and Chemical Biology
    2. Structural Biology and Molecular Biophysics

    Impact of the clinically approved BTK inhibitors on the conformation of full-length BTK and analysis of the development of BTK resistance mutations in chronic lymphocytic leukemia

    Raji E Joseph, Thomas E Wales ... Amy H Andreotti
    Research Advance

    Inhibition of Bruton’s tyrosine kinase (BTK) has proven to be highly effective in the treatment of B-cell malignancies such as chronic lymphocytic leukemia (CLL), autoimmune disorders, and multiple sclerosis. Since the approval of the first BTK inhibitor (BTKi), Ibrutinib, several other inhibitors including Acalabrutinib, Zanubrutinib, Tirabrutinib, and Pirtobrutinib have been clinically approved. All are covalent active site inhibitors, with the exception of the reversible active site inhibitor Pirtobrutinib. The large number of available inhibitors for the BTK target creates challenges in choosing the most appropriate BTKi for treatment. Side-by-side comparisons in CLL have shown that different inhibitors may differ in their treatment efficacy. Moreover, the nature of the resistance mutations that arise in patients appears to depend on the specific BTKi administered. We have previously shown that Ibrutinib binding to the kinase active site causes unanticipated long-range effects on the global conformation of BTK (Joseph et al., 2020). Here, we show that binding of each of the five approved BTKi to the kinase active site brings about distinct allosteric changes that alter the conformational equilibrium of full-length BTK. Additionally, we provide an explanation for the resistance mutation bias observed in CLL patients treated with different BTKi and characterize the mechanism of action of two common resistance mutations: BTK T474I and L528W.

    1. Biochemistry and Chemical Biology

    Target protein identification in live cells and organisms with a non-diffusive proximity tagging system

    Yingjie Sun, Changheng Li ... Youngnam N Jin
    Research Article

    Identifying target proteins for bioactive molecules is essential for understanding their mechanisms, developing improved derivatives, and minimizing off-target effects. Despite advances in target identification (target-ID) technologies, significant challenges remain, impeding drug development. Most target-ID methods use cell lysates, but maintaining an intact cellular context is vital for capturing specific drug–protein interactions, such as those with transient protein complexes and membrane-associated proteins. To address these limitations, we developed POST-IT (Pup-On-target for Small molecule Target Identification Technology), a non-diffusive proximity tagging system for live cells, orthogonal to the eukaryotic system. POST-IT utilizes an engineered fusion of proteasomal accessory factor A and HaloTag to transfer Pup to proximal proteins upon directly binding to the small molecule. After significant optimization to eliminate self-pupylation and polypupylation, minimize depupylation, and optimize chemical linkers, POST-IT successfully identified known targets and discovered a new binder, SEPHS2, for dasatinib, and VPS37C as a new target for hydroxychloroquine, enhancing our understanding these drugs’ mechanisms of action. Furthermore, we demonstrated the application of POST-IT in live zebrafish embryos, highlighting its potential for broad biological research and drug development.